Transforming growth factor beta 1 (TGF-f,1) produced in tumour tissue after chemotherapy acts as a lymphokine-activated killer attractant
1996

TGF-beta1 as a Killer Cell Attractant After Chemotherapy

Sample size: 6 publication Evidence: moderate

Author Information

Author(s): Y Kuramitsu, M Nishibel, M Kobayashi, Y Togashi, L Yuan, M Takizawa, F Okada, M Hosokawa

Primary Institution: Cancer Institute, Hokkaido University School of Medicine

Hypothesis

Does TGF-beta1 produced in tumor tissue after chemotherapy enhance the accumulation of lymphokine-activated killer (LAK) cells in tumors?

Conclusion

TGF-beta1 produced in tumor tissues after chemotherapy acts as a chemotactic factor for LAK cells, enhancing their accumulation in tumors.

Supporting Evidence

  • TGF-beta1 was detected in tumor tissues treated with cyclophosphamide, indicating its production after chemotherapy.
  • LAK-attractant activity was significantly higher in conditioned media from tumors treated with cyclophosphamide compared to untreated tumors.
  • Recombinant human TGF-beta1 showed LAK-attractant activity at concentrations of 0.1 ng/ml and 1 ng/ml.

Takeaway

After chemotherapy, a substance called TGF-beta1 helps special immune cells called LAK cells find and gather in tumors, which might help fight cancer better.

Methodology

The study used an under agarose migration assay to measure the chemotactic activity of conditioned media from tumor tissues treated with various anti-cancer drugs.

Participant Demographics

Female C57BL/6 mice, 8-12 weeks of age.

Statistical Information

P-Value

< 0.001

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication